
A new technique using patients’ own modified cells to treat Crohn’s disease has been proven to be effective in experiments using human cells, with a clinical trial of the treatment expected to start in the next six months.
Researchers at the NIHR Guy’s and St Thomas’ Biomedical Research Centre (BRC) developed the technique by studying white blood cells taken from patients who have Crohn’s disease, and comparing them to cells of healthy people. Their findings allowed cell therapy specialists in the BRC to develop a treatment involving taking patients’ cells, and growing them in a special culture so that they behave more like cells from healthy people.
The research, published in the journal Gastroenterology, shows that this technique is effective in human cells, meaning it is ready for use in a clinical trial. The proposed Tribute Trial will test whether the treatment is safe and effective for treating Crohn’s disease.
Crohn’s disease is a lifelong condition in which parts of the digestive system become severely inflamed, causing a range of symptoms such as diarrhoea, stomach aches, tiredness and weight loss. Its causes are unknown, but the immune system is known to play a part. The often debilitating condition is estimated to affect around 620,000 people in the UK.
Professor Graham Lord, previously Director of our BRC, led the research. He recently took up a role as Vice-President and Dean of the Faculty of Biology, Medicine and Health at the University of Manchester. He said:
“This is the next frontier in cell therapy, as we’re going beyond treating the symptoms of Crohn’s disease, and trying to reset the immune system to address the condition.
“It’s a real home-grown treatment in the sense that we started with observing cells and tissues donated by patients at Guy’s and St Thomas’, have developed a treatment, and are now starting to undertake trials, all at the Trust. It shows how central patients are to research, helping to create a treatment that might help thousands more people.”
Rachel Sawyer, a communications manager who is 50 and lives in Anerley in south east London, was diagnosed with Crohn’s disease in 2000 and treated at Guy’s and St Thomas’. Although her condition is now under control, she supports other people who have Crohn’s and runs the Twitter account @Bottomline_IBD.
She said: “One of the worst things for me was the unpredictability, particularly around needing the toilet in a hurry. Having Crohn’s completely re-routes your daily life and makes it hard to do the normal things most of us take for granted like going out socially or taking public transport. Even now, the fear of it is never really far from my mind.
“Another difficult thing is the stigma associated with bowel disease. It’s difficult to talk and be open about it, even with family and friends. I found life very isolating and challenging at times – and that’s something so many people with Crohn’s experience, regardless of whether they were diagnosed years ago or last month. For people diagnosed young, it can impact on the formative years of their life.
“Anything that could help people with Crohn’s have the confidence to go out and get back to being the people they were destined to be would be a game-changer.”
The researchers found that specialised white blood cells called regulatory T cells from Crohn’s patients produced less of a gut-specific protein called integrin ?4?7 than regulatory T cells from healthy people. Working with the specialists at the NIHR Guy’s and St Thomas’ BRC’s Advanced Therapies Manufacturing Platform, they developed a cell therapy technique based on these findings.
This technique involves developing cells from the Crohn’s disease patients with a molecule called RAR568, which restores healthy levels of integrin ?4?7. The cells are then given back to patients by intravenous infusion.
Learn more: Patients’ own cells could be the key to treating Crohn’s disease
The Latest on: Crohn’s disease
[google_news title=”” keyword=”Crohn’s disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Crohn’s disease
- The future of inflammatory bowel disease treatment: what is on the horizon?on July 25, 2024 at 6:37 am
Discover how new treatments in clinical trial phases for inflammatory bowel disease (IBD) could revolutionize care and address unmet needs.
- Teva and Sanofi Announce Accelerated Timeline for Anti-TL1A Phase 2b Program in Patients with Inflammatory Bowel Diseaseon July 24, 2024 at 10:30 pm
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Sanofi today announced an update to the timing for the anti-TL1A, duvakitug (formerly known as ...
- Professional Faqs: How Do I Healed From Crohn's Disease?on July 24, 2024 at 10:28 pm
Expert opinion from Mohan P. Abraham M.D., FAAFP (Family Physician) · 40 years of experience · USA Treatments can help manage condition but there is no known cure. Treatment includes medications, ...
- Professional Faqs: Is Cabbage Bad For You If You Have Crohn's Disease?on July 24, 2024 at 5:39 pm
CarzonBachelor degree in Human Nutrition · 4 years of experience · ArgentinaPeople with Crohn's disease should not eat raw vegetables because they may cause discomfort, pain, and gas. Raw cabbage is ...
- Crohn's Disease Newson July 22, 2024 at 5:00 pm
June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an important role in the disease and ...
- Risankizumab found to be noninferior, superior to ustekinumab for Crohn's diseaseon July 17, 2024 at 5:00 pm
For patients with moderate-to-severe Crohn's disease, risankizumab is noninferior to ustekinumab for clinical remission at week 24 and is superior for endoscopic remission at week 48, according to a ...
- Is Crohn’s Covered Under the Americans with Disabilities Act?on July 14, 2024 at 5:00 pm
Crohn’s disease is a type of disability covered by the Americans with Disabilities Act. However, certain rules and exceptions must be observed. Crohn’s disease is a type of inflammatory bowel ...
- Bowel drug breakthrough after 'holy grail' discovery marks step towards Crohn’s-free worldon July 14, 2024 at 8:56 am
More than half a million people in the UK have inflammatory bowel disease (IBD), the two main forms of which are Crohn’s disease and ulcerative colitis, with at least seven million affected globally ...
- Treatments and prevention strategies for Crohn’s diseaseon July 13, 2024 at 4:43 pm
Crohn’s disease is a chronic condition that affects the digestive tract, causing inflammation that can lead to a variety of symptoms like abdominal pain, diarrhea, weight loss, and fatigue. While ...
via Bing News